Skip to content
value.today

LianBio American Depositary Shares

LIANUnlisted company
$451 Mlast known market cap, Jan 2024 — no current value
Compare
World rank
—
no current market cap
Revenue
$0 M
Dec-2021 ending year
value.today research
Net income
$-196 M
value.today research
Employees
107
As on 2021
value.today research

LianBio American Depositary Shares in brief

LianBio American Depositary Shares is an unlisted company in the Healthcare sector, based in New Jersey, USA. In the year to Dec 2021 it had sales of $0 M and a net loss of $196 M. It employs about 107 people.

Written from the figures on this page, so it changes when they do. The date of each figure is under How current the figures are.

About LianBio American Depositary Shares

LianBio is a biopharmaceutical company that treat the specific cause of diseases like cardiovascular, oncology and respiratory. The company total assets are 279.2 million USD as on 2020. The headquarters is in USA.

LianBio American Depositary Shares timeline

1 events, 2021
  1. 2021
  2. 🔔
    · approximate
    Initial public offering on Nasdaq

Events of LianBio American Depositary Shares from the company record. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.

More about LianBio American Depositary Shares

Acquisitions and changes
No longer listed: ticker LIAN is not in the SEC's, the US exchanges' or FINRA's lists of traded securities (checked 14 November 2026).

Market cap history

$0 M$144 M$287 M$431 M$575 M20232024

World rank over time

▼ down 77 places since 2022
2022-01-07: #13160#13,16020222022-12-25: #18679#18,67920222023-07-30: #17653#17,65320232024-01-05: #13237#13,2372024

Rank in USA: #3,220 (Jan 2022) · #3,798 (Dec 2022) · #3,541 (Jul 2023) · #2,628 (Jan 2024)

Key ratios

market cap and latest results
P/E ratio
n/m (loss)
Price / sales
—
Price / book
—
Free cash flow yield
—
Net margin
—
Operating margin
—
Return on equity
-50.6%
Liabilities / assets
9.2%
Revenue per employee
$0 K
Profit per employee
$-1.8 M

Annual results

Revenue
$0 M
Operating income
—
Net income
$-196 M

Dec-2021 ending year

Balance sheet

Total assets
$426 M
Total liabilities
$39 M
Total equity
$387 M

Dec-2021 ending year

How LianBio American Depositary Shares compares in Healthcare

  • Revenue$0 M · higher than 0% of 1,807
CompanyMarket capP/ENet marginRev. growth
LianBio American Depositary Shares🇺🇸$451 M———
Eli Lilly and Company🇺🇸$1.20 T43.4×31.9%+44.7%
Johnson & Johnson🇺🇸$652.5 B40.5×16.2%+6.0%
AbbVie Inc.🇺🇸$514.0 B49.7×15.7%+8.6%
Roche Holding AG🇨🇭$370.3 B29.1×19.0%—
UnitedHealth Group Incorporated🇺🇸$367.7 B23.1×3.5%+11.8%
Merck & Co., Inc.🇺🇸$359.8 B146.7×3.6%+1.3%
Novartis AG🇨🇭$286.8 B20.5×24.7%—
Thermo Fisher Scientific Inc.🇺🇸$253.8 B35.9×14.9%+3.9%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

How current the figures are

Market cap:
Jan 5, 2024 (last known)
Annual results:
Dec-2021 ending year
Balance sheet:
Dec-2021 ending year
Employees:
As on 2021
Profile updated:
Nov 14, 2026

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at LianBio American Depositary Shares? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show LianBio American Depositary Shares's ranking or a chart on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about LianBio American Depositary Shares? Suggest a correction